FDA Warns Unilever and Dr Pepper on Improper Green Tea Statements

The Food and Drug Administration has warned beverage makers Dr Pepper Snapple Group Inc (DPS) and Unilever for making improper statements regarding green tea on product labels and web sites. – Reuters

Be the first to comment

Leave a Reply

Your email address will not be published.